|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 16609 |
FusionGeneSummary for HNRNPL_HNRNPL |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: HNRNPL_HNRNPL | Fusion gene ID: 16609 | Hgene | Tgene | Gene symbol | HNRNPL | HNRNPL | Gene ID | 3191 | 3191 |
| Gene name | heterogeneous nuclear ribonucleoprotein L | heterogeneous nuclear ribonucleoprotein L | |
| Synonyms | HNRPL|P/OKcl.14|hnRNP-L | HNRPL|P/OKcl.14|hnRNP-L | |
| Cytomap | 19q13.2 | 19q13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | heterogeneous nuclear ribonucleoprotein LhnRNP L | heterogeneous nuclear ribonucleoprotein LhnRNP L | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | P14866 | P14866 | |
| Ensembl transtripts involved in fusion gene | ENST00000221419, ENST00000600873, | ENST00000221419, ENST00000600873, | |
| Fusion gene scores | * DoF score | 9 X 10 X 5=450 | 2 X 3 X 2=12 |
| # samples | 10 | 3 | |
| ** MAII score | log2(10/450*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: HNRNPL [Title/Abstract] AND HNRNPL [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BQ343301 | HNRNPL | chr19 | 39333350 | - | HNRNPL | chr19 | 39333330 | + | ||
| ChiTaRS3.1 | AI800860 | HNRNPL | chr19 | 39332850 | + | HNRNPL | chr19 | 39331798 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000221419 | ENST00000221419 | HNRNPL | chr19 | 39333350 | - | HNRNPL | chr19 | 39333330 | + |
| intron-intron | ENST00000221419 | ENST00000600873 | HNRNPL | chr19 | 39333350 | - | HNRNPL | chr19 | 39333330 | + |
| intron-intron | ENST00000600873 | ENST00000221419 | HNRNPL | chr19 | 39333350 | - | HNRNPL | chr19 | 39333330 | + |
| intron-intron | ENST00000600873 | ENST00000600873 | HNRNPL | chr19 | 39333350 | - | HNRNPL | chr19 | 39333330 | + |
| intron-intron | ENST00000221419 | ENST00000221419 | HNRNPL | chr19 | 39332850 | + | HNRNPL | chr19 | 39331798 | + |
| intron-intron | ENST00000221419 | ENST00000600873 | HNRNPL | chr19 | 39332850 | + | HNRNPL | chr19 | 39331798 | + |
| intron-intron | ENST00000600873 | ENST00000221419 | HNRNPL | chr19 | 39332850 | + | HNRNPL | chr19 | 39331798 | + |
| intron-intron | ENST00000600873 | ENST00000600873 | HNRNPL | chr19 | 39332850 | + | HNRNPL | chr19 | 39331798 | + |
Top |
FusionProtFeatures for HNRNPL_HNRNPL |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| HNRNPL | HNRNPL |
| Splicing factor binding to exonic or intronic sites andacting as either an activator or repressor of exon inclusion.Exhibits a binding preference for CA-rich elements(PubMed:11809897, PubMed:22570490, PubMed:24164894,PubMed:25623890, PubMed:26051023). Component of the heterogeneousnuclear ribonucleoprotein (hnRNP) complexes and associated withmost nascent transcripts (PubMed:2687284). Associates, togetherwith APEX1, to the negative calcium responsive element (nCaRE) B2of the APEX2 promoter (PubMed:11809897).{ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:22570490,ECO:0000269|PubMed:25623890, ECO:0000269|PubMed:26051023,ECO:0000269|PubMed:2687284}. | Splicing factor binding to exonic or intronic sites andacting as either an activator or repressor of exon inclusion.Exhibits a binding preference for CA-rich elements(PubMed:11809897, PubMed:22570490, PubMed:24164894,PubMed:25623890, PubMed:26051023). Component of the heterogeneousnuclear ribonucleoprotein (hnRNP) complexes and associated withmost nascent transcripts (PubMed:2687284). Associates, togetherwith APEX1, to the negative calcium responsive element (nCaRE) B2of the APEX2 promoter (PubMed:11809897).{ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:22570490,ECO:0000269|PubMed:25623890, ECO:0000269|PubMed:26051023,ECO:0000269|PubMed:2687284}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for HNRNPL_HNRNPL |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for HNRNPL_HNRNPL |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for HNRNPL_HNRNPL |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for HNRNPL_HNRNPL |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | HNRNPL | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Hgene | HNRNPL | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Tgene | HNRNPL | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Tgene | HNRNPL | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|